ValiRx (LSE:VAL) PB Ratio : 0.74 (As of May. 14, 2024)

View and export this data going back to 2000. Start your Free Trial

What is ValiRx PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-14), ValiRx's share price is £0.0305. ValiRx's Book Value per Share for the quarter that ended in Jun. 2023 was £0.04. Hence, ValiRx's PB Ratio of today is 0.74.

The historical rank and industry rank for ValiRx's PB Ratio or its related term are showing as below:

LSE:VAL' s PB Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.17 Max: 4.94
Current: 0.74

During the past 13 years, ValiRx's highest PB Ratio was 4.94. The lowest was 0.01. And the median was 0.17.

LSE:VAL's PB Ratio is ranked better than
86.05% of 1312 companies
in the Biotechnology industry
Industry Median: 2.48 vs LSE:VAL: 0.74

During the past 12 months, ValiRx's average Book Value Per Share Growth Rate was 28.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -41.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -50.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -53.80% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ValiRx was -20.80% per year. The lowest was -64.40% per year. And the median was -52.05% per year.

Back to Basics: PB Ratio

ValiRx PB Ratio Historical Data

The historical data trend for ValiRx's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ValiRx PB Ratio Chart

ValiRx Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

PB Ratio

Get a 7-Day Free Trial

1.58

0.68

2.57

6.59

3.11

ValiRx Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
PB Ratio	Get a 7-Day Free Trial															2.93	6.59	3.36	3.11	1.77

Competitive Comparison of ValiRx's PB Ratio

For the Biotechnology subindustry, ValiRx's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ValiRx's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ValiRx's PB Ratio distribution charts can be found below:

* The bar in red indicates where ValiRx's PB Ratio falls into.

ValiRx PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

ValiRx's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2023)
	=	0.0305	/	0.041
	=	0.74

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

ValiRx (LSE:VAL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

ValiRx PB Ratio Related Terms

Thank you for viewing the detailed overview of ValiRx's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

ValiRx (LSE:VAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ValiRx PLC (LSE:VAL) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

EAJF:Germany

Address

4 Barling Way, Eliot Park Innovation Centre, Nuneaton, GBR, CV10 7RH

Website

https://www.valirx.com

ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.